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Abstract
Neuronal Per-Arnt-Sim homology (PAS) Factor 4 (NPAS4) is a neuronal activity-dependent transcription factor which
heterodimerises with ARNT2 to regulate genes involved in inhibitory synapse formation. NPAS4 functions to maintain
excitatory/inhibitory balance in neurons, while mouse models have shown it to play roles in memory formation, social
interaction and neurodegeneration. NPAS4 has therefore been implicated in a number of neuropsychiatric or
neurodegenerative diseases which are underpinned by defects in excitatory/inhibitory balance. Here we have explored a
broad set of non-synonymous human variants in NPAS4 and ARNT2 for disruption of NPAS4 function. We found two
variants in NPAS4 (F147S and E257K) and two variants in ARNT2 (R46W and R107H) which significantly reduced
transcriptional activity of the heterodimer on a luciferase reporter gene. Furthermore, we found that NPAS4.F147S was
unable to activate expression of the NPAS4 target gene BDNF due to reduced dimerisation with ARNT2. Homology
modelling predicts F147 in NPAS4 to lie at the dimer interface, where it appears to directly contribute to protein/protein
interaction. We also found that reduced transcriptional activation by ARNT2 R46W was due to disruption of nuclear
localisation. These results provide insight into the mechanisms of NPAS4/ARNT dimerisation and transcriptional activation
and have potential implications for cognitive phenotypic variation and diseases such as autism, schizophrenia and
dementia.
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Introduction
Basic Helix-Loop-Helix Per-Arnt-Sim homology (bHLH-PAS)
proteins are signal regulated and/or tissue specific dimeric
transcription factors involved in a diverse array of physiological
and pathological functions [1–3]. They mediate processes such as
the cellular response to hypoxia (Hypoxia Inducible Factors
(HIF1a/HIF2a)) [2], the maintenance of circadian rhythms
(Circadian Locomotor Output Cycles Kaput (CLOCK)) [4], the
clearance of environmental pollutants (Aryl hydrocarbon Receptor
(AhR)/Dioxin Receptor (DR)) [1], and appetite control (Single
minded 1 (Sim1)) [5,6]. The above bHLH-PAS transcription
factors must heterodimerise with an obligate nuclear partner
protein, Aryl hydrocarbon Receptor Nuclear Translator (ARNT/
ARNT2) or Brain and Muscle ARNT-Like (BMAL1/BMAL2), to
activate or repress gene expression[1]. Dimerisation is predomi-
nantly mediated through the conserved N-terminal bHLH and
PAS repeat domains (PASA and PASB) to allow binding to
asymmetric E-BOX-like elements in regulatory regions of target
genes [7–9].
Neuronal PAS factor 4 (NPAS4) is a bHLH-PAS transcription
factor whose expression and activity is tightly coupled with
neuronal activity [10,11]. Ischemia, seizure, neuronal depolarisa-
tion, and models of learning all rapidly and transiently increase
expression of NPAS4 [10,12,13]. In response, NPAS4 activates a
battery of genes to increase the number of inhibitory synapses,
maintaining homeostasis of neuron activity [10,14]. Not surpris-
ingly, NPAS4 null mice are hyperactive, prone to seizures, and
display several defects in social anxiety and cognitive impairments
similar to those observed in autism and schizophrenia [10,15].
NPAS4 null mice also have a much reduced life span due to
extensive neurodegeneration, thought to be caused by glutamate
neurotoxicity [16]. More recently, conditional deletion of NPAS4
in the CA3 region of the hippocampus in adult mice has shown it
is required for contextual memory formation [11].
Neuropsychiatric disorders encompass a diverse array of
phenotypes and while a strong genetic component has been
suggested, the precise genes involved have been difficult to identify
[15,17,18]. In addition, modifier or susceptibility genes are
hypothesised to be required in concert with other mutations to
drive aberrant neurological phenotypes [19,20]. Recent reports
from large scale whole genome and exome sequencing projects
have highlighted the contribution that rare, de novo variants make
to disease [19,21–23]. Indeed, the large spectrum of phenotypes
that underlie neuropsychiatric disease may reflect a multivaried
nature of deleterious, rare genetic variants associated with disease.
Many neuropsychiatric diseases, including schizophrenia and
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autism, are thought to have related defects which disrupt the
balance between neuronal excitation and inhibition [24–27].
There is strong evidence from loss of function mutations associated
with these diseases that synapse dysfunction may play a key role in
disrupting this homeostatic balance [17,28,29]. In addition,
glutamergic hyperexcitation, which may also arise from disruption
of the excitatory/inhibitory balance or other neuronal stressors,
has been linked to the progression of neurodegenerative disorders
[30,31].
Given NPAS4 is activated following neuronal activity to control
the balance of excitatory and inhibitory synapses, and that defects
in memory, social anxiety, age related neurodegeneration,
hyperactivity and seizures are observed in NPAS4 null mice,
NPAS4 has been implicated in a number of neuropsychiatric and
neurodegenerative diseases [15,16,29,32]. Here we sought to test
whether human variants in NPAS4 or ARNT2 might compromise
transcriptional function. We screened several variants listed in
public databases and found examples where single amino acid
changes in NPAS4 or ARNT2 resulted in mild or dramatic loss of
function. We elucidated mechanisms of disrupted heterodimerisa-
tion or impaired nuclear localisation to attenuate activity of the
NPAS4/ARNT2 complex. This study outlines a strategy to
highlight and prioritise non-synonymous variants in human
transcription factors which might then be screened in patient
cohorts to investigate their possible contribution to disease.
Materials and Methods
Cloning and Cell Culture
pCMV-hNPAS4-mycFlag was purchased from Origene (Rock-
ville,USA). NPAS4-mycFlag was subsequently subcloned into
pENTR1a (Invitrogen) using SmaI/EcoRV. pEF-IRESpuro-
hSIM1-2Myc and pEF-IRESneo-hARNT1, pEF-IRESneo-
hARNT2, pEF-IRESpuro-hARNT1-3xFlag, pEF-IRESneo-
hARNT2-3xFlag have been described previously [33]. pEFBOS-
Gtwy and pcDNA-FRT/TO-Gtwy were created by inserting
KpnI/EcoRV GtwyA from pLV410 [34] into either pEF-BOS or
pcDNA-FRT/TO. NPAS4, ARNT2 and SIM1 variants were
cloned using overlap extension PCR or Gibson Isothermal
assembly essentially as described [35,36] using Phusion proof
reading polymerase (New England Biolabs). Primers were
designed to incorporate the indicated human variants (Table S1)
and the mutations were confirmed by sequencing. NPAS4 variants
were either subcloned into pEFBOS-Gtwy or pcDNA5-FRT/TO-
Gtwy plasmids using LR recombination (Invitrogen). pcDNA3.2-
d2nucEGFP was created by first subcloning d2eGFP from
pd2eGFP-T4 N1 (Clonetech) into pENTR1a using EcoRI/NotI,
then D2nucEGFP was digested from pNSEN [37] with AgeI/
HindIII and inserted into pENTR1a-d2eGFP. pcDNA3.2-DEST
(Invitrogen) was then recombined with pENTR1a-d2nucEGFP by
LR recombination.
Human Embryonic Kidney HEK293T (ATCC, CCL-3216),
HEK293-TREX (Invitrogen) and Neuro2A (ATCC, CCL-131)
cells were maintained in DMEM medium supplemented with 10%
FCS, 1 mM L-glutamine, 100 units/ml penicillin, and 100 mg/ml
streptomycin. HEK293-TREX stable cell lines were generated
according to manufacturer instructions (Invitrogen). Briefly 66105
HEK293TREX cells were transfected with 2 mg of pOG44 and
200 ng of pcDNA5-FRT/TO-hNPAS4-mycFlag plasmid using
Fugene6 (Roche). 48 hrs after transfection the cells were expanded
and selected in 200 mg/ml Hygromycin B (Invitrogen) to generate
stable cell lines. At least two independently derived WT NPAS4
cell lines and one cell line for each variant were used for BDNF
exon I expression analysis. NPAS4 expression was induced with
1 mg/ml doxycyline for 24 hrs.
Transient transfections and luciferase assays
HEK293T cells in 24 well plates were transiently transfected
with a DNA cocktail containing 200 ng firefly luciferase reporter
plasmid pML-6xCME-Luc or empty pML-Luc control [38], 50 ng
each of ARNT1 or ARNT2 expression plasmid, pEF-IRESpuro-
hSIM1-2myc, pEF-IRESpuro-hSIM2-2myc [39,40] or pEFBOS-
hNPAS4-mycFlag expression vectors and 200 pg of phRL-CMV
Renilla luciferase reporter plasmid (Promega) using Fugene6
(Roche) according to the manufacturers’ instructions. Plasmid
concentrations were normalised using empty expression plasmids.
After 24 or 48 hrs, relative luciferase activities for each bHLH/
PAS variant were assayed using a DLR kit (Promega) and
normalized to relative WT activity. For immunoprecipitations,
1 mg of pCI-eGFP, 2 mg of ARNT2 and 2 mg of NPAS4
expression plasmids were cotransfected into 56105 293T cells
using Fugene6 (Roche).
RNA extraction, cDNA synthesis and quantitative real
time PCR
HEK293-TREX cells were lysed in 500 ml trizol (Invitrogen)
and RNA isolated. 2 mg of RNA was used in each reverse
transcription reaction (Superscript III, Invitrogen) and cDNA was
diluted 10 fold in 1X Tris-EDTA (TE) pH 8.0.for real time PCR.
Real time PCR was performed in triplicate using Fast SYBR
Green Master Mix (Applied Biosystems) on a StepOne Plus Real-
time PCR system (Applied Biosystems) using primers specific to
human BDNF exon I [41], NPAS4 [10] and RNA polymerase 2A
[42] and spanning an intron where possible. BDNF gene induction
by each NPAS4 variant was normalised to RNA polymerase 2A.
Melt curves of PCR products were analysed to confirm a single
amplicon and real time PCR results were analysed and ‘QGene’
analysis software [43].
Immunoblotting and Immunoprecipitations
For immunoprecipitations, cells were washed twice in PBS and
lysed in 20 mM HEPES, pH 8.0, 420 mM NaCl, 0.5% Igepal,
25% glycerol, 0.2 mM EDTA, 1.5 mM MgCl2, 1 mM DTT and
protease inhibitors (Sigma). 100 mg of protein whole cell extract
was diluted to 1 mg/ml in immunoprecipitation (IP) buffer
(20 mM HEPES, pH 8.0, 150 mM NaCl, 150 mM KCl, 0.1%
glycerol, 1 mM EDTA, 1 mM DTT and protease inhibitors) and
incubated with 50 mL of BSA blocked Flag M2 resin (Sigma). The
resin was washed twice with 1 mL of IP wash buffer (250 mM
NaCl, 20 mM HEPES pH 8.0, 0.1% Igepal, and 1 mM EDTA)
and the bound material boiled in 20 ml of SDS sample buffer.
Input sample (10%) and immunoprecipitations were then run on
7.5%SDS-PAGE gels and transferred to nitrocellulose. Lysates
from reporter gene assays were separated on 7.5% SDS-PAGE gel
and transferred to nitrocellulose. Proteins were detected using the
anti-ARNT2 (Santa Cruz), anti-FLAG (Sigma), anti-Myc (4A6,
Upstate) and anti-a-Tubulin antibodies (MCA78G, Serotec).
Primary antibodies were detected using horseradish peroxidise-
conjugated secondary antibodies and visualised using chemilumi-
nescence. Quantification of ARNT2 co-immunoprecipition band
intensity was estimated using ImageLab software (BioRad).
Immunofluorescence
pEF-IRESpuro-hARNT2-3xFlag or pEF-IRESpuro-
hARNT2.R46W-3xFlag (50 ng) were cotransfected with 200 ng
of pcDNA3.2-d2nucEGFP into HEK293T cells plated on Poly-D-
NPAS4 and ARNT2 Variants Disrupt Activity
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Lysine (70–150 KDa; Sigma) coated coverslips using Fugene6
(Roche). After 24 hrs, Cells were fixed 4% Paraformaldehyde
(PFA) for 20 mins, washed in PBS and permeablised using 2%
Triton-X-100/PBS for 10 mins. The fixed cells were then blocked
using horse serum, and ARNT2 detected using anti-Flag antibody
(1:1000; Sigma) and visualised using a TxRed-conjugated second-
ary antibody. Coverslips were mounted onto slides using Prolong
Gold mounting medium containing DAPI (Invitrogen) and images
taken using a Ziess deconvolution microscope. Images were then
false coloured and overlayed using ImageJ imaging software [44].
Homology modeling
Homology models were created in the ICM-Pro program suite
[45] using the homology add-on [46,47]. Individual subunits of the
heterodimer were first created separately using the sequence for
human NPAS4 (Uniprot number Q8IUM7) and for human Arnt2
(Uniprot number Q9HBZ2). A search for homologous structures
in the Protein Data Bank was performed and the Clock-BMAL
structure was the structure with the highest homology (PDB:4F3L)
[48]. The NPAS4 homology model was created using the
CLOCK protein as a three-dimensional template and the ARNT2
homology model was created using BMAL as the three-
dimensional molecular template. After creation of individual
subunit models, they were both subjected to regularization and
model refinement within ICM-Pro (energy minimization, optimi-
zation of geometry, and easing of clashing side-chains). Both
subunits were then docked together using the CLOCK-BMAL
structure to guide the docking. Further model refinement and
regularization was then performed to ensure the integrity of the
dimer interface. Finally, many loops were identified and subjected
to loop modeling to improve clashing at the dimer interface using
the ICM-Pro loop modeling utility [49]. Figures were created
using PyMOL (The PyMOL Molecular Graphics System, Version
1.2r3pre, Schro¨dinger, LLC.).
Statistical Analysis
Statistical significance was performed using GraphPad Prism 5
program for Windows (GraphPad Software Inc.) and evaluated by
the Student’s t test or ANOVA with the level of significance set at
p,0.05. ANOVA statistical analysis was performed on log
transformed data with Tukey’s post hoc analysis. Data are
expressed as mean 6SEM unless otherwise indicated.
Results
To investigate whether variants in NPAS4 would disrupt
function we examined protein coding variants from the 1000
genomes project, the NHLBI exome sequencing project and the
NCBI SNP database [50–52]. Initially we examined 13 non-
synonymous NPAS4 variants, which represented all reported
mismatch variants at the time we initiated this study, for their
ability to activate a bHLH-PAS responsive luciferase reporter gene
containing six repeats of a bHLH-PAS core binding element
(pML-6xCME-Luc, [33]). The single nucleotide variants were
spread throughout the protein sequence and spanned the C-
terminal and PAS regions (Fig. 1A). Coexpression of wild type
(WT) NPAS4 and ARNT2, but not ARNT2 alone, strongly
activated the reporter gene (Fig. 1B). The overwhelming majority
of variants were able to activate the reporter to a similar extent as
WT NPAS4, however, variant F147S completely ablated the
ability of NPAS4 to activate the reporter (Fig. 1B).
Although NPAS4 expression most strongly overlaps with
ARNT2 within the brain, in biochemical experiments NPAS4
appears to show little bias between binding and activating
transcription with ARNT1 or ARNT2 [53,54]. To explore this
further we then tested the ability of a subset of NPAS4 variants,
including F147S, to activate the reporter gene in HEK293T cells
in combination with either ARNT1 or ARNT2 as the dimerisation
partner (Fig. 1C). NPAS4 was able to strongly activate the reporter
when dimerising with either ARNT1 or ARNT2, although the
F147S variant remained inactive irrespective of coexpression with
ARNT1 or ARNT2 (P,0.0001, Fig. 1C). The loss of function
NPAS4.F147S protein was expressed at similar levels and size
(,100 KDa) to that of WT NPAS4 or other variants by western
blot analysis (Fig. 1D). Given that NPAS4 is a neuronal
transcription factor, we were interested in establishing whether
there were neuron specific effects not observed in HEK293T cells.
Using Neuro2A (N2A) cells we found that WT NPAS4 was active
with either ARNT1 or ARNT2, but the F147S variant again failed
to activate the reporter gene (P,0.0001, Fig. 1E). We did not
observe any consistent changes in any of the other variants or in
the overall protein expression of these variants in N2A cells (Fig. E
and F).
To further characterise the mechanism of the loss of function
NPAS4.F147S variant we generated HEK293-TREX inducible
cell lines where NPAS4 or NPAS4 variant expression can be
induced from a defined locus upon treatment with doxycycline.
This allows for equivalent expression of NPAS4 variants,
facilitating direct comparison of activities. NPAS4 has been
previously shown to be a critical activator of Brain Derived
Neurotrophic Factor (BDNF) following neuronal depolarisation
[10,41]. Furthermore, defective BDNF expression and function is
also an important contributor to neurological disease [55,56]. We
therefore next investigated whether the NPAS4.F147S and a
subset of variants spanning the C-terminus could induce BDNF
exon I expression using 293TREX cells. Overexpression of WT
NPAS4 and the C-terminal variants were able to strongly induce
the expression of BDNF exon I, however, there was a ,90%
reduction in the ability of F147S to induce BDNF exon I
expression (Fig. 2A). Similar reduction in the ability of
NPAS4.F147S to activate BDNF exon I expression was found in
transient transfection experiments where ARNT2 was coexpressed
(Fig. S1). We did not observe any significant differences in the
ability of any other NPAS4 variants to activate BDNF I expression
(Fig. 2A).
The NPAS4.F147S variation was located towards the end of the
PASA domain in a region where amino acids important for
dimerisation have been previously identified (Fig.S2A and Fig. 1A)
[33,57]. We were therefore interested to test whether the F to S
conversion could disrupt dimerisation between NPAS4 and
ARNT2. We used co-immunoprecipitation to show that
NPAS4.F147S failed to form a heterodimer with ARNT2
(Fig. 2B). Other NPAS4 variants, which showed near wild type
activities on the reporter gene (Fig 1C), showed similar ARNT2
co-immunoprecipitation to wild type NPAS4. Homology model-
ling of NPAS4 and ARNT2 using the crystal structure for
CLOCK and BMAL as a template revealed F147 to lie on the
surface (Fig. 3A) and position at the proposed dimerisation
interface between NPAS4 and ARNT2 (Fig. 3B) [48]. The
phenylalanine residue appears to be in close proximity to several
hydrophobic residues in ARNT2 and may make contacts within
this interface to promote dimerisation (Fig. 3A). Substitution of the
large, hydrophobic phenylalanine with a small, polar serine may
therefore explain the loss in dimerisation. We hypothesised that
substitution of F147 with an alanine may partially disrupt function
by removing the larger phenylalanine residue, but maintaining
hydrophobicity. We therefore tested this mutant and found
NPAS4.F147A significantly (P,0.001) decreased reporter gene
NPAS4 and ARNT2 Variants Disrupt Activity
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Figure 1. Functional Analysis of human NPAS4 Variants. A, Schematic of domains within NPAS4 showing positions of analysed non-
synonymous variants. B, A screen of NPAS4-mycFlag variants using NPAS4/ARNT2 activation of a reporter gene (6xCME-Luc) in HEK293T cells
transfected with NPAS4-MycFlag and ARNT2 expression vectors. Values represent average percentage activity of WT NPAS4-mycFlag 6SD of two
NPAS4 and ARNT2 Variants Disrupt Activity
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activity to approximately 65% of wt, supporting our hypothesis
(Fig. 4A). Furthermore, mutation of the corresponding phenylal-
anine residue to alanine in related bHLH/PAS proteins SIM1
(SIM1.F160A) and SIM2 (SIM2.F160A) also significantly (P,
0.001) reduced reporter gene activities to approximately 60% and
40%, respectively, suggesting this mechanism of dimerisation may
be shared among bHLH-PAS transcription factors (Fig. 4B).
NPAS4.F147S and NPAS4.F147A also showed significantly (P,
0.0001 and P,0.001, respectively) reduced dimerization with
endogenous ARNT2 in co-immunoprecipition experiments com-
pared to WT NPAS4 (Fig. 4C and 4D). Dimerisation with
ARNT2 appeared to be greater with NPAS4.F147A than
NPAS4.F147S, consistent with reporter gene data. Alignment of
the human bHLH-PAS transcription factors revealed that the
phenylalanine at this position was conserved among all the bHLH-
PAS transcription factors, suggesting that this may represent an
important amino acid for a conserved mode of dimerisation
(Figure S2A).
Recently we have found a number of Loss of Function (LoF),
non-synonymous variants of SIM1 in a cohort of children
displaying early onset, morbid obesity[58,59]. A number of these
LoF SIM1 variants were clustered around PASA and PASB
domains. In addition, a number of residues within a homologous
region of PASB have been shown to be important for dimerisation
of CLOCK and BMAL [48]. New variants from recent
sequencing projects became available during this study and we
identified one additional variant in NPAS4 (E257K) and two
variants in SIM1 (G254E and G254R) which lay within this region
of clustered LoF mutations (Figure S2B). As these variants
replaced well conserved residues and had drastically altered side
chain chemistry, we reasoned they might alter protein activities.
Using luciferase reporter gene assays we found that the NPAS4
E257K variant significantly (p,0.05) reduced activity to ,70%
when compared to WT (Fig. 5A). The reduced reporter activity
observed with the NPAS4.E257K mutation did not appear to be
due a reduction in dimerisation with ARNT2 (Fig. 4C and 4D) or
protein expression (Fig. 5B). SIM1 G254E and G254R both
reduced luciferase reporter activity, however only SIM1.G254R
reached statistical significance (G245E, p.0.05; G254R, p,0.01).
The SIM1.G254R variant reduced reporter activity to ,60% of
WT, which may in part be due to a reduction in SIM1 protein
expression (Fig 5B).
Since our data revealed certain variants in NPAS4 to disrupt the
transcriptional output from NPAS4, we then predicted that
variants in ARNT2 might indirectly disrupt NPAS4 dependent
transcriptional output. We therefore examined single nucleotide
variants in ARNT2, concentrating on those that invoked dramatic
changes in side chain chemistry within functional N-terminal
domains where LoF variants were likely to occur. We selected and
tested four variants in ARNT2, R46W, R107H, R402Q and
W410R, for their ability to activate the 6xCME-Luciferase
reporter gene in combination with NPAS4. Expression of NPAS4
alone was unable to activate the reporter, however when ARNT2
was coexpressed we observed strong activation (Fig. 5C). Both
ARNT2.R46W and ARNT2.R107H significantly (P,0.01 and
P,0.05, respectively) reduced activation of the reporter to 55%
Figure 2. NPAS4 Variant F147S reduces dimerisation with ARNT2 and fails to activate BDNF expression. A, 293TREX cells containing site
specific, stable integration of WT NPAS4-mycFlag, NPAS4-mycFlag variants or an empty vector were induced with 1 mg/ml doxycycline for 24 hrs and
Brain Derived Neurotrophic Factor (BDNF) Exon I mRNA expression measured by quantitative real-time PCR and normalised to RNA Polymerase 2A.
Data are mean 6SEM of at least 4 independent experiments; WT is an average of two independently derived cell lines and least 4 independent
experiments. Statistical significance is calculated using an ANOVA compared to WT NPAS4-mycFlag, ****p,0.0001. B, Immunoblotting of whole cell
extracts and a-Flag coimmunoprecipitates from HEK293T cells transiently transfected with NPAS4-MycFlag and ARNT2 expression constructs. a-Flag
Abs used to detect NPAS4-MycFlag and a-ARNT2 Abs used to detect overexpressed ARNT2. Data are representative of three independent
experiments.
doi:10.1371/journal.pone.0085768.g002
independent experiments. C and E, NPAS4-MycFlag variant activation of the 6xCME-Luc reporter gene upon co-expression of ARNT1 or ARNT2 as the
dimerisation partner in HEK293T cells (C) or Neuro2A cells (E). Data are mean percentage activity of WT NPAS4-mycFlag 6SEM of at least 3
independent experiments. Statistical significance was calculated using an ANOVA compared to WT NPAS4-mycFlag. Cell lysates from reporter assays
in C and E were separated by SDS-PAGE and NPAS4-mycFlag protein detected by immunoblotting using a-Flag antibodies, with a-tubulin was used
as a loading control. Representative western blots of NPAS4-mycFlag variants are shown for HEK293T cells (D) and Neuro2A cells (F). ****p,0.0001.
doi:10.1371/journal.pone.0085768.g001
NPAS4 and ARNT2 Variants Disrupt Activity
PLOS ONE | www.plosone.org 5 January 2014 | Volume 9 | Issue 1 | e85768
and 65% compared to WT ARNT2, respectively. No significant
differences were observed with ARNT2.R402Q or
ARNT2.W410R (Fig. 5C). Expression of these ARNT2 variants
was comparable to WT ARNT2 (Fig. 5D). Previously, it has been
shown that constitutively nuclear localisation of ARNT1 is
controlled by a small N-terminal bi-partite nuclear localisation
sequence (NLS) [60]. Alignment of ARNT1 and ARNT2 revealed
that ARNT2 also shared this NLS and that R46W is within a set of
basic residues that comprise the NLS (Fig. 6A). We hypothesised
that the LoF exhibited by the ARNT2.R46W variant may be due
to loss of nuclear localisation and therefore performed immuno-
cytochemistry on Flag tagged WT or ARNT2.R46W expressed in
HEK293T cells (Fig. 6B). As expected, WT ARNT2 was
constitutively nuclear in almost all transfected cells, whereas
ARNT2.R46W was cytoplasmic in the majority of transfected cells
(Fig. 6B). We conclude that weak reporter gene activity of variant
R46W is therefore due to deficient nuclear import. The
ARNT2.R107H variant mildly impaired activity. R107 lies within
a proposed helix of the bHLH domain of ARNT2 and mapping
this amino acid on the homology model of ARNT2 predicts that
R107 is also surface exposed, positioned at the interface between
NPAS4 and ARNT2. The R to H transition may slightly weaken
dimerisation between NPAS4 and ARNT2 although this was not
evident from co-immunoprecipition experiments with NPAS4
(data not shown).
In summary, we have analysed a series of natural human
variants in NPAS4 and ARNT2 and discovered a subset which
compromise transcriptional activation. LoF variants are clustered
within domains with known roles in dimerisation and nuclear
localisation. Taken together, this data suggests that while many
single amino acid variants in the NPAS4 and ARNT2 transcrip-
tional complex may not compromise activity, distinct sites in the
N-terminal functional domains are sensitive to alteration and
warrant further investigation into possible links with neurological
disorders.
Discussion
Protein coding variants are estimated to be abundantly
generated in healthy individuals, but can also be important
contributors to disease [51,61]. The notion of de novo or rare
variant generation as drivers of complex diseases such as autism is
being increasingly appreciated [21,23]. Although large scale
sequencing projects have produced bioinformatic estimations for
the contribution of natural protein coding variation to protein
dysfunction, this has not been addressed experimentally [61].
Intellectual disability, autism and schizophrenia have been linked
to mutations in synaptic proteins, some of which have been shown
to underpin defects in synapse structure, function or homeostatic
balance in animal models [28,62–64]. It has therefore been
hypothesised that alterations to activity-dependent neuronal
signalling may disrupt neuronal homeostasis as a common
mechanism in neuropsychiatric disease [17,29].
NPAS4 is a transcription factor critical for maintaining
homeostatic balance of excitation/inhibition within neurons and
has been implicated in several neurological diseases [11,15,29,32].
Mice lacking NPAS4 exhibit many hallmarks of both neuropsy-
chiatric and neurodegenerative diseases, but as yet this transcrip-
tion factor has not been linked to any human disorder. While this
may seem surprising, many of these diseases are multifaceted, do
not manifest until later in life and may be dependent upon
additional environmental or genetic susceptibility factors.
The rapid expansion in genome sequencing data has recently
provided a wealth of human protein coding variants with little or
no associated phenotypic information. Here we tested the effects of
several human protein coding variants in NPAS4 and ARNT2 on
activity of the NPAS4/ARNT2 transcription factor complex. We
initially screened all NPAS4 non-synonymous coding variants
available in the dbSNP database at the outset of the study, in the
context of an NPAS4/ARNT2 heterodimer. We found
NPAS4.F147S to have a near complete loss of function on both
Figure 3. Homology model highlighting residue Phe147 of NPAS4. NPAS4 is colored green and ARNT2 is colored yellow. A) The
NPAS4 subunit is depicted as a surface representation. The location of Phe147 is shown by red color. B) The NPAS4-ARNT2 heterodimer is depicted as
a ribbons diagram. Phe147 is shown at the interface with side chain shown as sticks colored red, together with amino acids within 3.5 angstroms. Phe
147 is part of a hydrophobic pocket formed with ARNT2 residues (Leu 133, Leu 141) and NPAS4 residues (Leu 146, Trp 182).
doi:10.1371/journal.pone.0085768.g003
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a reporter gene and the endogenous BDNF target gene, which was
a consequence of disrupted dimerisation with ARNT2. In contrast,
the other twelve NPAS4 variants we screened failed to significantly
reduce induction of the reporter gene and/or BDNF. We note that
the majority of these variants (8/13) lie in a region spanning 300
amino acids following PASB (Fig 1A), which is predicted to be
Figure 4. NPAS4.F147A, SIM1.F160A, and SIM2.F160A show reduced activities on a reporter gene. A, Comparison of WT NPAS4-mycFlag
and NPAS4.F147A-mycFlag activities on reporter gene 6xCME-Luc in HEK293T cells transfected with NPAS4-MycFlag and ARNT2 expression vectors. B,
Comparison of WT SIM-2myc proteins with SIM1.F160A-2myc and SIM2.F160A-2myc variants on reporter gene 6xCME-Luc in HEK 293T cells cells
transfected with SIM1-2Myc, SIM2-2Myc and ARNT2 expression vectors. C. Immunoblotting of whole cell extracts and a-Flag coimmunoprecipitates
from HEK293T cells transiently transfected with NPAS4-MycFlag. a-Flag Abs used to detect NPAS4-MycFlag and a-ARNT2 Abs used to detect
endogenous ARNT2. D. ARNT2 coimmunopreciption band intensity quantitation of 3 independent a-Flag coimmunoprecipitation experiments. Data
are mean relative luciferase activities 6SEM of 3 experiments. Statistical significance is calculated using an unpaired two tailed students t-test (A and
B) or ANOVA (D) compared to WT.***p,0.001, ****p,0.0001.
doi:10.1371/journal.pone.0085768.g004
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largely unstructured and seemingly tolerant for variation. As SNP
databases expanded, we tested variants in NPAS4 and ARNT2
which we predicted might be prone to altered activity due to
position in key domains and distinct change in amino acid side
chain chemistry. This led to the discovery that variant E257K in
NPAS4 had a mild attenuation of activity (,70% of WT), an
observation recapitulated with similarly located variants (G254E,
G254R) within the related bHLH-PAS SIM1 transcription factor
(Fig 5A). In addition, we successfully predicted and verified the
R46W variant in ARNT2, which lies within a nuclear localisation
sequence, to have significantly weaker activity than wild type due
to attenuated nuclear uptake.
We recently found that rare variants within the bHLH-PAS
transcription factor SIM1 were present in severely obese children
or adults with hyperphagic Prada-Willi Like syndrome [58,59].
While non-synonymous variants with partial loss of function were
found throughout SIM1, those with the most severe effects on
activity were clustered within N-terminal domains important for
dimerisation and DNA binding. Furthermore, using a reverse
bacterial two-hybrid system, we have previously defined several
amino acids within the PASA domain of bHLH-PAS heterodimers
that are important for dimerisation [33]. These tend to be
clustered within a conserved b-sheet towards the end of PASA,
where the NPAS4 variant F147 resides (Figure S2A). Using
homology modelling of NPAS4 and ARNT2 based on the
Figure 5. Partial loss of activity variants found in NPAS4, SIM1 and ARNT2. A, Variants of NPAS4-mycFlag, and SIM1-2myc were
coexpressed with ARNT2 and assessed for activation of reporter gene 6xCME-Luc in HEK293T cells. Data are presented as average percentage
activities (6SEM of 3 independent experiments) of the relevant WT heterodimers which have been normalised 100%. B, Western blot of reporter
assay lysates from A to verify expression of hSIM1-2myc and hNPAS4-mycFlag (using a-Myc antibodies), hARNT2 (a-ARNT2 antibodies) and tubulin (a-
tubulin antibodies). C, NPAS4-mycFlag activation of reporter gene 6xCME-Luc in combination with the indicated ARNT2-3xFlag variants in HEK293T
cells. Data are presented as average percentage activities (6SEM of 3 independent experiments) of WT NPAS4-mycFlag/ARNT2-3xFlag heterodimer
which has been normalised to 100%. D, Western blot of reporter assay lysates from C to detect expressed hNPAS4-MycFlag and hARNT2-3xFlag with
a-flag antibodies, or tubulin using a-tubulin antibodies. Statistical significance was calculated using an ANOVA comparing relative luciferase activities
to WT, * p,0.05, **p,0.01.
doi:10.1371/journal.pone.0085768.g005
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CLOCK/BMAL heterodimer crystal structure we confirmed that
F147 likely lies at the NPAS4/ARNT2 PASA dimer interface.
Furthermore, maintenance of hydrophobicity by substitution with
alanine at this position only partially disrupted reporter activation
and dimerisation (Fig. 4A, Fig. 4C, and Fig. 4D), suggesting that
the presence of a large hydrophobic residue is required for optimal
dimerisation. Sequence alignments of human bHLH-PAS tran-
scription factors also revealed that the F147 residue is highly
conserved at the corresponding position in other bHLH-PAS
transcription factors (Figure S2A). Consistent with this notion,
replacing this phenylalanine with alanine in SIM1 and SIM2 also
led to partial loss of function of the SIM/ARNT2 heterodimers
(Fig 4B). Within the CLOCK/BMAL structure the A’a helix of
CLOCK PASA make strong interactions with the b-sheet faces of
BMAL, and conversely the BMAL A’a helix makes contacts with
the b-sheet face of CLOCK to mediate dimerisation [48]. This
helps explain the lack of NPAS4/ARNT2 interaction for
NPAS4.F147S, and also why a screen for PAS A mutations in
ARNT which inhibit AhR/ARNT dimerisation recovered mod-
ifications within the surface exposed b-sheet face of ARNT [33].
Taken together this supports the notion of F147 being a key
residue for dimerisation among bHLH-PAS transcription factors
and outlines the importance of this region for intermolecular
interaction and heterodimerisation between PASA domains
[33,48].
This study of human NPAS4 and ARNT2 non-synonymous
variants is the first screen that we are aware of that assess the
specific activities of natural transcription factor variants. While
protein coding variants in NPAS4 have yet to be associated with a
human disorder, the region surrounding NPAS4 has been found to
be deleted in a boy with intellectual disability [65], and a region
encompassing NPAS4 has been found to be associated with
bipolar disorder [20]. Effects of the variants we tested includes
near complete loss of function of the NPAS4/ARNT2 heterodi-
mer (NPAS4.F147S) and partial loss of function (NPAS4.E257K,
ARNT2.R46W and ARNT2.R107H). While we cannot assess the
impact of these variants on phenotype, experiments using NPAS4
deficient mice suggest affected phenotypes may encompass low
severity mild memory deficits and social interaction deficits,
through to more severe conditions of epilepsy, schizophrenia or
age related neurodegeneration [10,11,15,16]. Our results now
seem to warrant targeted sequencing of NPAS4 in cohorts of
neuropsychiatric and/or dementia patients.
Finally, the number of new variants identified from ongoing
sequencing projects has significantly expanded since the initiation
of this study. The methods outlined here provide a rapid and
efficient way of testing for loss of function or weak activity
variations in bHLH-PAS transcription factors and can be used to
examine other disease related bHLH-PAS transcription factors
such as SIM1 or HIF1a, as additional variants from new
sequencing projects becomes available.
Supporting Information
Figure S1 NPAS4.F147S has reduced ability to induce
BDNF exon I mRNA expression in HEK293T cells.
HEK293T cells transiently transfected with NPAS4-MycFlag,
ARNT2, or control expression vectors. Brain Derived Neuro-
trophic Factor (BDNF) exon I mRNA expression measured by
quantitative real-time PCR and normalised to RNA Polymerase
2A. Data are mean 6SEM of 3 independent experiments.
Figure 6. Variant R46W in ARNT2 disrupts nuclear localisation. A, Alignment of the N-terminal basic residues of ARNT1 nuclear localisation
sequence with WT ARNT2 and ARNT2.R46W. B, Immunofluorescence of HEK293T cells transfected with either WT ARNT2-3xFlag or ARNT2.R46W-
3xFlag expression vectors using a-Flag antibodies (Red) and nuclei stained with DAPI (Blue).
doi:10.1371/journal.pone.0085768.g006
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Statistical significance is calculated using an ANOVA compared to
WT NPAS4-mycFlag. ** p,0.01, ***p,0.001.
(TIF)
Figure S2 Conservation of the PAS domains of bHLH-
PAS transcription factors using multiple sequence
alignments. Multiple sequence alignments of selected regions
of A) basic helix loop helix (bHLH) and PASA regions or B) the
PASB regions of human bHLH-PAS transcription factors.
Conserved residues of selected variants (ARNT2 R107,
NPAS4.F147, NPAS4.G208, NPAS4.E257 and SIM1 G254) in
this study are highlighted in red, activity deficient variants from
CLOCK/BMAL structure [1], ARNT/AhR [2,3] or SIM1 [4,5]
are in magenta.
(DOCX)
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